CSTL · Castle Biosciences Inc

$24.70 -0.79 (-3.08%) At close · Jul 24

Market Cap

$748.69M

30.33M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$715,572	—	$5,283,595	—	$921,657	$20,250	$6,941,074
Kristen M. Oelschlager	COO	$506,415	$13,926	$1,563,738	—	$342,701	$20,150	$2,446,931
Tobin W. Juvenal	Chief Commercial Officer	$506,415	$13,926	$1,563,738	—	$342,701	$20,150	$2,446,931

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$686,400	—	—	—	$893,350	$26,234	$1,605,984
Frank Stokes	CFO	$488,800	$4,888	—	—	$316,742	$69,820	$880,250
Tobin W. Juvenal	Chief Commercial Officer	$482,300	$14,469	—	—	$312,530	$19,800	$829,099
Kristen M. Oelschlager	COO	$482,300	$9,646	—	—	$312,530	$24,008	$828,484

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$660,000	—	$6,102,902	—	$771,375	$18,300	$7,552,577
Tobin W. Juvenal	Chief Commercial Officer	$455,000	$13,650	$1,919,356	—	$295,750	$18,300	$2,702,056
Kristen M. Oelschlager	COO	$455,000	$13,650	$1,919,356	—	$295,750	$18,300	$2,702,056
Frank Stokes	CFO	$470,000	$4,700	$1,757,713	—	$305,500	$69,160	$2,607,073

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$625,000	—	$2,500,003	$2,656,954	$722,500	$17,400	$6,521,857
Frank Stokes	CFO	$450,000	$4,500	$999,993	$1,062,350	$289,800	$58,708	$2,865,351
Kristen M. Oelschlager	COO	$425,000	$8,500	$999,993	$1,062,350	$273,700	$17,400	$2,786,943
Tobin W. Juvenal	Chief Commercial Officer	$425,000	$8,500	$999,993	$1,062,350	$273,700	$17,400	$2,786,943

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$550,000	—	$1,268,982	$3,056,657	$457,600	$11,400	$5,344,639
Frank Stokes	CFO	$400,000	$4,000	$473,280	$1,087,530	$208,000	$44,257	$2,217,067
Bernhard E. Spiess	Chief Business Officer	$350,000	$3,150	$354,960	$806,861	$163,800	$11,400	$1,335,211

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$769,562	$18,690	—	$2,991,141	$341,760	$11,200	$4,132,353
Frank Stokes	CFO	$327,117	$7,748	—	$968,897	$141,680	$52,790	$1,498,232
Federico A. Monzon	Chief Medical Officer	$326,781	$8,101	—	$644,397	$148,133	$11,200	$1,138,612

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Derek Maetzold	CEO	$409,500	—	—	$161,040	$206,000	$14,218	$790,758
Frank Stokes	CFO	$275,000	—	—	$177,347	$96,250	$44,732	$593,329
Federico A. Monzon	Chief Medical Officer	$317,075	—	—	$33,387	$112,400	$11,000	$473,862

Key facts CIK 1447362 CUSIP 14843C105 13F (30d) 23 filings 23 filers Visit website Investor relations